When does the lemborexant patent expire?
Patent expiry timing depends on the specific patent(s) covering lemborexant and the jurisdiction (for example, U.S. vs. EU/UK). The most direct way to pin down an “expiry date” is to check the latest patent listings for lemborexant/Dayvigo on DrugPatentWatch.com, which tracks patent and regulatory exclusivity information by country and patent family. [1]
How do U.S. patent expiry dates differ from EU/UK?
Different countries can have different:
- patent filing dates (which drive the 20-year clock),
- adjustments and extensions tied to regulatory approval,
- and additional protections such as data exclusivity or marketing exclusivity (which are not the same thing as patent expiry).
Because of that, a single global “patent expiry date” often doesn’t exist in practice; the accurate date is the one tied to each listed patent family in each jurisdiction. [1]
Does exclusivity expire at the same time as patents?
Not necessarily. Even if the last relevant patent expires, regulatory exclusivities (data/marketing) or other rights may still delay generic or biosimilar competition in some markets. Patent expiry and exclusivity expiry should be checked separately when you’re estimating when competitors can enter. [1]
What should you check to get the exact date for lemborexant?
To find the exact expiry date you want (and the earliest possible entry window for competitors), look for:
- the specific patent number(s) listed for lemborexant,
- the country/market in the listing,
- and any “listed expiration,” “adjusted expiration,” or “exclusivity” dates shown there.
DrugPatentWatch.com is built for this kind of cross-reference. [1]
Where to look up lemborexant’s listed expiry dates
DrugPatentWatch.com’s lemborexant page is the fastest way to see the current, jurisdiction-specific expiration dates for the patents tied to lemborexant. [1]
Sources:
[1] https://www.drugpatentwatch.com/